{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:17:38Z","timestamp":1778764658446,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014667","name":"British Neuropathological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021170","name":"Brain Tumour Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105814","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:33:22Z","timestamp":1750793602000},"page":"105814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas"],"prefix":"10.1016","volume":"117","author":[{"given":"Maryam","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeasmin","family":"Akther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-9267","authenticated-orcid":false,"given":"Claire L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Banton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Ercolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathreena M.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyam","family":"Laraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Woznica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Bryan","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-437X","authenticated-orcid":false,"given":"Leandro Jos\u00e9","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-1025","authenticated-orcid":false,"given":"Clemens Oliver","family":"Hanemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105814_bib1","doi-asserted-by":"crossref","DOI":"10.2217\/cns-2021-0003","article-title":"Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas","volume":"10","author":"Maggio","year":"2021","journal-title":"CNS Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12970","article-title":"Prognostic impact of genetic alterations and methylation classes in meningioma","volume":"32","author":"Berghoff","year":"2022","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ebiom.2025.105814_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1078-0432.CCR-18-0641","article-title":"Phosphoproteomic and kinomic signature of clinically aggressive grade I (1.5) meningiomas reveals Rb1 signaling as a novel mediator and biomarker","volume":"26","author":"Parada","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2025.105814_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2025.105814_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","article-title":"Associations of meningioma molecular subgroup and tumor recurrence","volume":"23","author":"Youngblood","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105814_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2025.105814_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fsurg.2016.00040","article-title":"Meningioma genomics: diagnostic, prognostic, and therapeutic applications","volume":"3","author":"Bi","year":"2016","journal-title":"Front Surg"},{"key":"10.1016\/j.ebiom.2025.105814_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2025.105814_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","article-title":"Genomic landscape of meningiomas","volume":"20","author":"Lee","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ebiom.2025.105814_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-031-29750-2_11","article-title":"Genomic landscape of meningiomas","volume":"1416","author":"Wang","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ebiom.2025.105814_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2025.105814_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1126550","article-title":"Specific gene expression signatures of low grade meningiomas","volume":"13","author":"Tsitsikov","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","article-title":"Genetic severity score predicts clinical phenotype in NF2","volume":"54","author":"Halliday","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.ebiom.2025.105814_bib17","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib18","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041273","article-title":"A rapid robust method for subgrouping non-NF2 meningiomas according to genotype and detection of lower levels of M2 macrophages in AKT1 E17K mutated tumours","volume":"21","author":"Adams","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.105814_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jmedgenet-2012-100918","article-title":"wANNOVAR: annotating genetic variants for personal genomes via the web","volume":"49","author":"Chang","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.ebiom.2025.105814_bib21","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2025.105814_bib22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2025.105814_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ygeno.2018.05.013","article-title":"Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity","volume":"111","author":"Hassan","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.ebiom.2025.105814_bib24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2025.105814_bib25","doi-asserted-by":"crossref","first-page":"11640","DOI":"10.1038\/s41598-021-91142-1","article-title":"Confirming putative variants at \u2264 5% allele frequency using allele enrichment and Sanger sequencing","volume":"11","author":"Yan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105814_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40291-020-00462-x","article-title":"Use of an integrated pan-cancer oncology enrichment next-generation sequencing assay to measure tumour mutational burden and detect clinically actionable variants","volume":"24","author":"Pestinger","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ebiom.2025.105814_bib27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.ebiom.2025.105814_bib28","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.ebiom.2025.105814_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2025.105814_bib30","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/brain\/awac342","article-title":"Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma","volume":"146","author":"Laraba","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.105814_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40478-023-01677-9","article-title":"A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas","volume":"11","author":"van de Weijer","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ebiom.2025.105814_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178322","article-title":"Genomic profile of human meningioma cell lines","volume":"12","author":"Mei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105814_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cancers11040545","article-title":"Identification of KIF11 as a novel target in meningioma","volume":"11","author":"Jungwirth","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ebiom.2025.105814_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.004","article-title":"Receptor tyrosine kinase inhibition by regorafenib\/sorafenib inhibits growth and invasion of meningioma cells","volume":"73","author":"Tuchen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2025.105814_bib35","article-title":"Reporting animal research: explanation and elaboration for the arrive guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ebiom.2025.105814_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12766","article-title":"BRAIN UK: accessing NHS tissue archives for neuroscience research","volume":"48","author":"Nicoll","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ebiom.2025.105814_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ebiom.2018.12.048","article-title":"Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism","volume":"40","author":"Dunn","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105814_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ebiom.2017.01.020","article-title":"Global proteome and phospho-proteome analysis of merlin-deficient meningioma and schwannoma identifies PDLIM2 as a novel therapeutic target","volume":"16","author":"Bassiri","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105814_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ijms22020560","article-title":"Fibulin-2: a novel biomarker for differentiating grade ii from grade i meningiomas","volume":"22","author":"Sofela","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.105814_bib40","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2025.105814_bib41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105814_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2025.105814_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nop012","article-title":"DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma","volume":"12","author":"Rajaraman","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib44","doi-asserted-by":"crossref","first-page":"35848","DOI":"10.18632\/oncotarget.16261","article-title":"Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype","volume":"8","author":"Carrera-Lasfuentes","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2025.105814_bib45","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/MCB.20.11.3817-3830.2000","article-title":"Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors","volume":"20","author":"Arcaro","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2025.105814_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mito.2010.03.001","article-title":"Succinate dehydrogenase \u2013 assembly, regulation and role in human disease","volume":"10","author":"Rutter","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ebiom.2025.105814_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","article-title":"Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2025.105814_bib48","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1021\/acs.jproteome.9b00490","article-title":"Parallel reaction monitoring-mass spectrometry (PRM-MS)-based targeted proteomic surrogates for intrinsic subtypes in breast cancer: comparative analysis with immunohistochemical phenotypes","volume":"19","author":"Park","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ebiom.2025.105814_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ebiom.2025.105814_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13132","article-title":"Clinical implementation of integrated molecular-morphologic risk prediction for meningioma","volume":"33","author":"Hielscher","year":"2023","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ebiom.2025.105814_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.716415","article-title":"Annexin A3, a calcium-dependent phospholipid-binding protein: implication in cancer","volume":"8","author":"Yang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ebiom.2025.105814_bib52","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1073\/pnas.0803978105","article-title":"Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication","volume":"105","author":"Ibarra","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105814_bib53","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer","volume":"118","author":"Jur\u00edkov\u00e1","year":"2016","journal-title":"Acta Histochem"},{"key":"10.1016\/j.ebiom.2025.105814_bib54","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/labinvest.3700307","article-title":"Establishment of a benign meningioma cell line by hTERT-mediated immortalization","volume":"85","author":"P\u00fcttmann","year":"2005","journal-title":"Lab Investig"},{"key":"10.1016\/j.ebiom.2025.105814_bib55","first-page":"3893","article-title":"CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer","volume":"127","author":"Macpherson","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ebiom.2025.105814_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.devcel.2011.11.008","article-title":"Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes\/lysosomes and drive cancer progression","volume":"22","author":"Dozynkiewicz","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.ebiom.2025.105814_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14206","article-title":"Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity","volume":"8","author":"Hernandez-Fernaud","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105814_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.devcel.2020.06.009","article-title":"Single-cell transcriptomic analyses of the developing meninges reveal meningeal fibroblast diversity and function","volume":"54","author":"DeSisto","year":"2020","journal-title":"Dev Cell"},{"key":"10.1016\/j.ebiom.2025.105814_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202483","article-title":"Integrated meta-omics analysis unveils the pathways modulating tumorigenesis and proliferation in high-grade meningioma","volume":"12","author":"Biswas","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2025.105814_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103812","article-title":"Dysfunctional oxidative phosphorylation shunts branched-chain amino acid catabolism onto lipogenesis in skeletal muscle","volume":"39","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2025.105814_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2025.105814_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ebiom.2025.105814_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41984-022-00173-x","article-title":"Novel evaluation of the expression patterns CD44 and MMP9 proteins in intracranial meningiomas and their relationship to the overall survival","volume":"37","author":"Abd Elhakeem","year":"2022","journal-title":"Egypt J Neurosurg"},{"key":"10.1016\/j.ebiom.2025.105814_bib64","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3171\/2023.11.JNS231884","article-title":"Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema","volume":"141","author":"Sawaya","year":"2024","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ebiom.2025.105814_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/neup.12266","article-title":"Activation of multiple growth factor signalling pathways is frequent in meningiomas","volume":"36","author":"Hilton","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.ebiom.2025.105814_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-022-01260-z","article-title":"Signaling pathways in brain tumors and therapeutic interventions","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2025.105814_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-021-03874-9","article-title":"The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications","volume":"156","author":"Robert","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ebiom.2025.105814_bib69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40478-019-0793-4","article-title":"Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT","volume":"7","author":"Jungwirth","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ebiom.2025.105814_bib70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLU.0000000000003477","article-title":"FDG PET\/CT of benign psammomatous meningioma effacing the medulla","volume":"46","author":"Chuang","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ebiom.2025.105814_bib71","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neurad.2017.06.003","article-title":"Imaging features of intracranial psammomatous meningioma","volume":"44","author":"Liu","year":"2017","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.ebiom.2025.105814_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/02688690120114174","article-title":"Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein","volume":"16","author":"Hunt","year":"2002","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.ebiom.2025.105814_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.579599","article-title":"Meningioma: a review of clinicopathological and molecular aspects","volume":"10","author":"Huntoon","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2025.105814_bib74","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.apsb.2022.11.023","article-title":"Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ebiom.2025.105814_bib75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","article-title":"Emerging systemic treatment options in meningioma","volume":"161","author":"Mair","year":"2023","journal-title":"J Neurooncol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:18:32Z","timestamp":1752614312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425002580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":75,"alternative-id":["S2352396425002580"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105814","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105814"}}